Xylem (NYSE:XYL – Free Report) had its price target increased by Robert W. Baird from $151.00 to $155.00 in a research report released on Friday, Benzinga reports. They currently have an outperform rating on the industrial products company’s stock.
A number of other analysts also recently weighed in on XYL. BNP Paribas started coverage on Xylem in a report on Tuesday, March 12th. They set an outperform rating and a $150.00 price target for the company. Royal Bank of Canada lifted their target price on Xylem from $140.00 to $145.00 and gave the stock an outperform rating in a report on Wednesday, February 7th. Stifel Nicolaus increased their price target on Xylem from $136.00 to $150.00 and gave the stock a buy rating in a report on Wednesday, February 7th. Citigroup boosted their target price on shares of Xylem from $126.00 to $139.00 and gave the company a neutral rating in a research report on Monday, April 8th. Finally, Oppenheimer lifted their price target on shares of Xylem from $133.00 to $142.00 and gave the company an outperform rating in a research note on Thursday, April 18th. Five equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of Moderate Buy and an average target price of $140.70.
Xylem Trading Up 0.9 %
Xylem (NYSE:XYL – Get Free Report) last announced its earnings results on Thursday, May 2nd. The industrial products company reported $0.90 EPS for the quarter, beating the consensus estimate of $0.84 by $0.06. The business had revenue of $2.03 billion for the quarter, compared to analysts’ expectations of $2 billion. Xylem had a return on equity of 8.95% and a net margin of 8.34%. The firm’s revenue was up 40.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.72 earnings per share. On average, analysts expect that Xylem will post 4.24 EPS for the current year.
Xylem Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, March 20th. Investors of record on Wednesday, February 21st were given a dividend of $0.36 per share. This is a boost from Xylem’s previous quarterly dividend of $0.33. The ex-dividend date of this dividend was Tuesday, February 20th. This represents a $1.44 annualized dividend and a dividend yield of 1.05%. Xylem’s payout ratio is presently 51.25%.
Insider Activity at Xylem
In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of Xylem stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total transaction of $122,890.00. Following the transaction, the chief accounting officer now directly owns 2,935 shares of the company’s stock, valued at approximately $360,682.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total value of $122,890.00. Following the completion of the transaction, the chief accounting officer now directly owns 2,935 shares of the company’s stock, valued at $360,682.15. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Franz Cerwinka sold 2,408 shares of Xylem stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total value of $293,270.32. Following the sale, the senior vice president now owns 11,750 shares in the company, valued at $1,431,032.50. The disclosure for this sale can be found here. 0.27% of the stock is currently owned by insiders.
Institutional Trading of Xylem
A number of large investors have recently added to or reduced their stakes in XYL. Norges Bank bought a new position in shares of Xylem during the 4th quarter valued at approximately $198,207,000. Artisan Partners Limited Partnership bought a new position in Xylem during the fourth quarter valued at $187,207,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main increased its position in Xylem by 1,503.7% in the fourth quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 1,649,926 shares of the industrial products company’s stock worth $188,685,000 after buying an additional 1,547,043 shares during the last quarter. Kodai Capital Management LP bought a new stake in shares of Xylem in the fourth quarter valued at $133,945,000. Finally, Invesco Ltd. lifted its position in shares of Xylem by 35.1% during the 3rd quarter. Invesco Ltd. now owns 4,182,821 shares of the industrial products company’s stock valued at $380,762,000 after buying an additional 1,086,102 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.
Xylem Company Profile
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
See Also
- Five stocks we like better than Xylem
- The How and Why of Investing in Biotech Stocks
- MarketBeat Week in Review – 4/29 – 5/3
- 3 Best Fintech Stocks for a Portfolio Boost
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.